Related Experiment Videos
[Risk factors and preventive measures]
1Mitsukoshi Health and Welfare Foundation.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 3, 1999
Summary
Lowering LDL cholesterol reduces coronary artery disease (CAD) risk. However, other factors like HDL, triglycerides, and Lp(a) also impact cardiovascular events, suggesting a broader approach to risk reduction.
Area of Science:
- Cardiovascular Medicine
- Lipidology
- Preventive Cardiology
Context:
- Clinical trials confirm LDL cholesterol reduction's role in decreasing coronary artery disease (CAD) risk.
- Statin therapy significantly lowers LDL but does not eliminate all cardiovascular events.
Purpose:
- To highlight the limitations of solely focusing on LDL cholesterol reduction for cardiovascular risk management.
- To advocate for the consideration of additional lipid and non-lipid parameters in assessing and mitigating CAD risk.
Summary:
- While statins effectively lower LDL cholesterol (24-37%), residual risk suggests other factors are crucial.
- Key parameters to consider include HDL cholesterol, triglycerides, lipoprotein(a) [Lp(a)], LDL particle size, and LDL oxidation susceptibility.
- Beyond lipids, fibrinolytic activity, hyperinsulinemia, hyperhomocysteinemia, and alcohol consumption are identified as significant contributing factors.
Impact:
- Broadens the understanding of cardiovascular risk beyond LDL cholesterol.
- Informs more comprehensive strategies for preventing coronary artery disease.
- Suggests a multi-faceted approach for maximizing therapeutic benefits in cardiovascular risk reduction.